VivaScope 1500 and 3000 imaging systems for detecting skin cancer lesions

Evidence-based recommendations on the VivaScope 1500 and 3000 imaging systems for detecting skin cancer lesions.

Last reviewed: 14 January 2020

We reviewed the evidence and found nothing new that affects the recommendations in this guidance. See the review decision for more details.

Next review: This guidance will be reviewed if there is new evidence that is likely to affect the recommendations.

Diagnostics guidance 19 has been migrated to HealthTech guidance 388.

Guidance development process

How we develop NICE diagnostics guidance